Supplementary Material from Molecular and Immunologic Signatures are Related to Clinical Benefit from Treatment with Vocimagene Amiretrorepvec (Toca 511) and 5-Fluorocytosine (Toca FC) in Patients with Glioma
William P. Accomando(Retriev Technologies (United States)), Derek Ostertag, Ash A. Alizadeh(California Institute for Regenerative Medicine), Aki Nakao(Palo Alto Institute), Douglas J. Jolly(Retriev Technologies (United States)), Ali Haghighi(Chemistry and Chemical Engineering Research Center of Iran), Oscar R. Diago(ArmaGen (United States)), Daniel J. Hogan(Retriev Technologies (United States)), Dawn Gammon(ArmaGen (United States)), Aliz R. Rao(Directorate-General for Interpretation), Maximilian Diehn(Stanford University), Harry E. Gruber, Aaron M. Newman(California Institute for Regenerative Medicine)
Cited by 0
Related Papers
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
|Nature|2000|10k
The Immune Landscape of Cancer
|Immunity|2018|6.3k
Relation of Gene Expression Phenotype to Immunoglobulin Mutation Genotype in B Cell Chronic Lymphocytic Leukemia
|The Journal of Experimental Medicine|2001|1.1k
Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review
|Journal of Clinical Oncology|2018|925
The Immune Landscape of Cancer
|Immunity|2019|806